Company intelligence / Profile preview

Omeq Medical

Ownership: Private
Development stage: Other

Overview

Omeq Medical has developed EPiFINDER, a single-use smart device that attaches to standard epidural needles. It provides real-time objective feedback by measuring tissue resistance at the needle tip to accurately identify the epidural space. The device received FDA clearance and aims to improve safety and accuracy in epidural injections by reducing operator dependence and complications. Clinical results are not detailed in public sources but regulatory clearance indicates successful validation.

Therapeutic areas: NeurologyOther
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Trendlines Group (incubator/investor partnership)Israel Innovation AuthorityAdvisory board collaborations with Rambam Hospital (Israel)Bologna University Hospital (Europe)Johns Hopkins Hospital (US)

Beyond the preview

Go deeper on Omeq Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Omeq Medical.

Explore the full profile